Cordyceps militaris alleviates non-alcoholic fatty liver disease in ob/ob mice

被引:1
|
作者
Choi, Ha-Neul [1 ]
Jang, Yang-Hee [1 ]
Kim, Min-Joo [2 ]
Seo, Min Jeong [3 ,4 ]
Kang, Byoung Won [4 ]
Jeong, Yong Kee [3 ,4 ]
Kim, Jung-In [1 ]
机构
[1] Inje Univ, Sch Food & Life Sci, Dept Smart Food & Drugs, Gimhae 621749, Gyeongnam, South Korea
[2] Hurom Co Ltd, Lab Nutr Anal, Gyeongnam 660701, South Korea
[3] Dong A Univ, Dept Biotechnol, Pusan 604714, South Korea
[4] Dong A Univ, Medifarm Ind Res Ctr, Pusan 604714, South Korea
关键词
Cordyceps militaris; non-alcoholic fatty liver disease (NAFLD); triglyceride; antioxidant; ob/ob mice; INSULIN-RESISTANCE; HEPATIC STEATOSIS; MOUSE MODELS; OBESITY; EXTRACT; STEATOHEPATITIS; INFLAMMATION; SINENSIS; GLUCOSE; TISSUE;
D O I
10.4162/nrp.2014.8.1.172
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
BACKGROUND/OBJECTIVES: Non-alcoholic fatty liver disease (NAFLD) is becoming an important public health problem as metabolic syndrome and type 2 diabetes have become epidemic. In this study we investigated the protective effect of Cordyceps militaris (C militaris) against NAFLD in an obese mouse model. MATERIALS/METHODS: Four-week-old male ob/ob mice were fed an AIN-93G diet or a diet containing 1% C militaris water extract for 10 weeks after 1 week of adaptation. Serum glucose, insulin, free fatty acid (FFA), alanine transaminase (ALT), and proinflammatory cytokines were measured. Hepatic levels of lipids, glutathione (GSH), and lipid peroxide were determined. RESULTS: Consumption of C militaris significantly decreased serum glucose, as well as homeostasis model assessment for insulin resistance (HOMA-IR), in ob/ob mice. In addition to lowering serum FFA levels, C militaris also significantly decreased hepatic total lipids and triglyceride contents. Serum ALT activities and tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) levels were reduced by C militaris. Consumption of C militaris increased hepatic GSH and reduced lipid peroxide levels. CONCLUSIONS: These results indicate that C militaris can exert protective effects against development of NAFLD, partly by reducing inflammatory cytokines and improving hepatic antioxidant status in ob/ob mice.
引用
收藏
页码:172 / 176
页数:5
相关论文
共 50 条
  • [41] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [42] Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice
    Lin, Chih-Wen
    Zhang, Hao
    Li, Min
    Xiong, Xiwen
    Chen, Xi
    Chen, Xiaoyun
    Dong, Xiaocheng C.
    Yin, Xiao-Ming
    JOURNAL OF HEPATOLOGY, 2013, 58 (05) : 993 - 999
  • [43] Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
    Burke, A
    Lucey, MR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 686 - 693
  • [44] The effect of endurance training on non-alcoholic fatty liver disease in mice
    Melo, Luma
    Bilici, Merve
    Hagar, Amit
    Klaunig, James E.
    PHYSIOLOGICAL REPORTS, 2021, 9 (15):
  • [45] NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC FATTY PANCREAS DISEASE: A NEW INTRIGUING ASSOCIATION?
    Della Corte, Claudia
    Mosca, Antonella
    Sartorelli, Maria Rita
    Comparcola, Donatella
    Liccardo, Daniela
    Alterio, Arianna
    Lucidi, Vincenzina
    Nobili, Valerio
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : E101 - E101
  • [46] NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS RELATED TO NON-ALCOHOLIC FATTY PANCREAS DISEASE (NAFPD)
    van Geenen, Erwin-Jan M.
    Smits, Mark M.
    Schreuder, Tim C.
    Bloemena, Elisabeth
    van der Peet, Donald L.
    Mulder, Chris J.
    HEPATOLOGY, 2009, 50 (04) : 788A - 788A
  • [47] Establishment of a mice nutritional non-alcoholic fatty liver disease model
    Cong, Weina
    Tao, Rongya
    Ye, Fei
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 298 - 298
  • [48] Elucidation of non-alcoholic fatty liver disease immunopathogenesis in humanized mice
    Her, Z.
    Tan, S. Y.
    Liu, M.
    Chan, X. Y.
    Tan, W. W. S.
    Yong, K. S. M.
    Zheng, Z.
    Loh, E.
    Chang, K. T. E.
    Tan, T. C.
    Chen, Q.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S19 - S19
  • [49] The effects of the voglibose on non-alcoholic fatty liver disease in mice model
    Bae, Jaehyun
    Lee, Ji Young
    Shin, Eugene
    Lee, Minyoung
    Lee, Yong-Ho
    Lee, Byung-Wan
    Kang, Eun Seok
    Cha, Bong-Soo
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [50] Repairing Effect of Fucoxanthin on Non-alcoholic Fatty Liver Disease in Mice
    Ren X.
    Zheng J.
    Tian X.
    Cao H.
    Li H.
    Tang Y.
    Yang Z.
    Shipin Kexue/Food Science, 2024, 45 (03): : 42 - 52